Influenza A virus H7N9 vaccine (Novavax)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza A virus H7N9 vaccine (Novavax)

Drug Alias Name甲型流感病毒H7N9疫苗 - NovavaxA (H7N9) influenza vaccine candidateH7N9 Virus-Like Particle (VLP) Influenza vaccine (recombinant)A (H7N9) vaccine

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovavax

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovavax

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A